Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal discomfort, bloating, and altered bowel habits. Unlike IBD, IBS does not involve visible structural inflammation but is strongly influenced by gut-brain interactions, diet, stress, and micro biome changes.
Emerging studies suggest that disruptions in gut micro biota composition, intestinal sensitivity, and nervous system signaling play key roles in IBS symptoms. Dietary modifications, probiotics, and stress management strategies are commonly used to improve symptom control and patient quality of life. Research continues to explore more targeted and effective treatment options.
This session will highlight current understanding, diagnostic approaches, and evidence-based management strategies for IBS. Participants will explore the latest findings in micro biome research, dietary therapy, and personalized treatment approaches for functional gut disorders.